Low-dose growth hormone inhibits 11 beta-hydroxysteroid dehydrogenase type 1 but has no effect upon fat mass in patients with simple obesity.
GH has potent effects on adipocyte biology, stimulating lipolysis but also promoting preadipocyte proliferation. In addition, GH, acting through IGF-I, inhibits 11 beta-hydroxysteroid dehydrogenase type 1 (11 beta-HSD1), which converts the inactive glucocorticoid, cortisone (E), to active cortisol (...
Asıl Yazarlar: | Tomlinson, J, Crabtree, N, Clark, P, Holder, G, Toogood, A, Shackleton, C, Stewart, P |
---|---|
Materyal Türü: | Journal article |
Dil: | English |
Baskı/Yayın Bilgisi: |
2003
|
Benzer Materyaller
-
Cortisol metabolism and the role of 11beta-hydroxysteroid dehydrogenase.
Yazar:: Tomlinson, J, ve diğerleri
Baskı/Yayın Bilgisi: (2001) -
Weight loss increases 11beta-hydroxysteroid dehydrogenase type 1 expression in human adipose tissue.
Yazar:: Tomlinson, J, ve diğerleri
Baskı/Yayın Bilgisi: (2004) -
Cortisol, 11 beta-hydroxysteroid dehydrogenase type 1 and central obesity.
Yazar:: Stewart, P, ve diğerleri
Baskı/Yayın Bilgisi: (2002) -
The functional consequences of 11beta-hydroxysteroid dehydrogenase expression in adipose tissue.
Yazar:: Tomlinson, J, ve diğerleri
Baskı/Yayın Bilgisi: (2002) -
The role of 11 beta-hydroxysteroid dehydrogenase in central obesity and osteoporosis.
Yazar:: Tomlinson, J, ve diğerleri
Baskı/Yayın Bilgisi: (2000)